Yuhan Corp. (KO:000100) — Market Cap & Net Worth
Market Cap & Net Worth: Yuhan Corp. (000100)
Yuhan Corp. (KO:000100) has a market capitalization of $4.57 Billion (₩6.74 Trillion) as of May 4, 2026. Listed on the KO stock exchange, this Korea-based company holds position #3805 globally and #100 in its home market, demonstrating a -3.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuhan Corp.'s stock price ₩91600.00 by its total outstanding shares 73615781 (73.62 Million). Analyse cash efficiency ratio of Yuhan Corp. to see how efficiently the company converts income to cash.
Yuhan Corp. Market Cap History: 2015 to 2026
Yuhan Corp.'s market capitalization history from 2015 to 2026. Data shows growth from $1.74 Billion to $4.57 Billion (10.12% CAGR).
Yuhan Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuhan Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Yuhan Corp.'s market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.08x
Yuhan Corp.'s market cap is 0.08 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.74 Billion | $1.13 Trillion | $126.05 Billion | 0.00x | 0.01x |
| 2016 | $1.35 Billion | $1.32 Trillion | $161.25 Billion | 0.00x | 0.01x |
| 2017 | $1.57 Billion | $1.46 Trillion | $109.03 Billion | 0.00x | 0.01x |
| 2018 | $1.55 Billion | $1.52 Trillion | $57.48 Billion | 0.00x | 0.03x |
| 2019 | $1.90 Billion | $1.48 Trillion | $40.01 Billion | 0.00x | 0.05x |
| 2020 | $3.19 Billion | $1.62 Trillion | $192.76 Billion | 0.00x | 0.02x |
| 2021 | $2.79 Billion | $1.69 Trillion | $102.58 Billion | 0.00x | 0.03x |
| 2022 | $2.72 Billion | $1.78 Trillion | $95.14 Billion | 0.00x | 0.03x |
| 2023 | $3.43 Billion | $1.86 Trillion | $136.20 Billion | 0.00x | 0.03x |
| 2024 | $5.96 Billion | $2.07 Trillion | $70.69 Billion | 0.00x | 0.08x |
Competitor Companies of 000100 by Market Capitalization
Companies near Yuhan Corp. in the global market cap rankings as of May 4, 2026.
Key companies related to Yuhan Corp. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
Yuhan Corp. Historical Marketcap From 2015 to 2026
Between 2015 and today, Yuhan Corp.'s market cap moved from $1.74 Billion to $ 4.57 Billion, with a yearly change of 10.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩4.57 Billion | -18.51% |
| 2025 | ₩5.61 Billion | -5.94% |
| 2024 | ₩5.96 Billion | +73.69% |
| 2023 | ₩3.43 Billion | +26.29% |
| 2022 | ₩2.72 Billion | -2.57% |
| 2021 | ₩2.79 Billion | -12.60% |
| 2020 | ₩3.19 Billion | +67.63% |
| 2019 | ₩1.90 Billion | +22.53% |
| 2018 | ₩1.55 Billion | -0.96% |
| 2017 | ₩1.57 Billion | +16.39% |
| 2016 | ₩1.35 Billion | -22.62% |
| 2015 | ₩1.74 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Yuhan Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.57 Billion USD |
| MoneyControl | $4.57 Billion USD |
| MarketWatch | $4.57 Billion USD |
| marketcap.company | $4.57 Billion USD |
| Reuters | $4.57 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Yuhan Corp.
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.